In this report, overexpression of Ep-CAM (Ep-CAMhi) was associated with higher tumor size, hormone receptor negativity status, and Ki-67 positivity status, which is consistent with previous reports that used the exact antibody clone (VU-1D9) and scoring method (H-score) [29,30,31]. Here, NR4A1 is linked to neoplasm.